Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss, net of tax	Unearned ESOP Shares
Balances at beginning of period (in shares) at Dec. 31, 2021	9,125,759
Balances at beginning of period at Dec. 31, 2021	$ 157,879		$ 91	$ 72,298	$ 86,162		$ 174	$ (846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,068				6,068
Other comprehensive income (loss), net of tax	$ (4,988)						(4,988)
Exercise of stock options (in shares)	4,481
Exercise of stock options	$ 48			48
Issuance of common stock - restricted stock awards, net (in shares)	32,212
Issuance of common stock - restricted stock awards, net(1)	$ 0		0	0
Compensation related to stock options and restricted stock awards	314			314
Allocation of ESOP shares	$ 942			378				564
Repurchase and retirement of common stock (in shares)	(57,711)
Repurchase and retirement of common stock	$ (977)		0	(977)
Canceled common stock - restricted stock awards (in shares)	(13,208)
Canceled common stock - restricted stock awards	$ (226)			(226)
Cash dividend declared and paid	$ (2,164)				(2,164)
Balances at end of period (in shares) at Jun. 30, 2022	9,091,533
Balances at end of period at Jun. 30, 2022	$ 156,896		91	71,835	90,066		(4,814)	(282)
Balances at beginning of period (in shares) at Mar. 31, 2022	9,107,977
Balances at beginning of period at Mar. 31, 2022	$ 157,757		91	71,780	88,339		(1,889)	(564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,808				2,808
Other comprehensive income (loss), net of tax	$ (2,925)						(2,925)
Exercise of stock options (in shares)	2,481
Exercise of stock options	$ 27			27
Issuance of common stock - restricted stock awards, net (in shares)	(1,998)
Issuance of common stock - restricted stock awards, net(1)	$ 0		0
Compensation related to stock options and restricted stock awards	125			125
Allocation of ESOP shares	$ 467			185				282
Repurchase and retirement of common stock (in shares)	(16,927)
Repurchase and retirement of common stock	$ (282)		0	(282)
Cash dividend declared and paid	$ (1,081)				(1,081)
Balances at end of period (in shares) at Jun. 30, 2022	9,091,533
Balances at end of period at Jun. 30, 2022	$ 156,896		91	71,835	90,066		(4,814)	$ (282)
Balances at beginning of period (in shares) at Dec. 31, 2022	9,127,595
Balances at beginning of period at Dec. 31, 2022	$ 160,360	$ (395)	91	72,424	95,059	$ 395	(7,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,610				3,610
Other comprehensive income (loss), net of tax	$ (2,603)						(2,603)
Exercise of stock options (in shares)	0
Issuance of common stock - restricted stock awards, net (in shares)	27,618
Issuance of common stock - restricted stock awards, net(1)	$ 1		1
Compensation related to stock options and restricted stock awards	$ 227			227
Canceled common stock - restricted stock awards (in shares)	(7,127)
Canceled common stock - restricted stock awards	$ (107)			(107)
Cash dividend declared and paid	$ (2,378)				(2,378)
Balances at end of period (in shares) at Jun. 30, 2023	9,148,086
Balances at end of period at Jun. 30, 2023	$ 158,715		92	72,544	95,896		(9,817)
Balances at beginning of period (in shares) at Mar. 31, 2023	9,148,086
Balances at beginning of period at Mar. 31, 2023	$ 159,645		92	72,445	95,597		(8,489)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,488				1,488
Other comprehensive income (loss), net of tax	$ (1,328)						(1,328)
Exercise of stock options (in shares)	0
Compensation related to stock options and restricted stock awards	$ 99			99
Cash dividend declared and paid	$ (1,189)				(1,189)
Balances at end of period (in shares) at Jun. 30, 2023	9,148,086
Balances at end of period at Jun. 30, 2023	$ 158,715		$ 92	$ 72,544	$ 95,896		$ (9,817)